Target intelligence / Profile preview

Olfactory receptor family 52 subfamily Z member 1 pseudogene (OR52Z1P)

Target
OR52Z1P
Molecular classification
Pseudogene, G protein-coupled receptor (predicted, if functional allele), Receptor (odorant receptor superfamily, when functional)
01

Overview

Olfactory receptor family 52 subfamily Z member 1 pseudogene (OR52Z1P) is classified as a **pseudogene** within the olfactory receptor family, meaning it generally does not produce functional protein in the majority of individuals[2][5]. Olfactory receptors overall are members of the **class A G protein-coupled receptor (GPCR)** family, structurally characterized by seven transmembrane domains and functioning in **odorant recognition and signal transduction** in the nasal epithelium[2][3][4]. However, OR52Z1P is a **segregating pseudogene**: in some people, a variant allele encodes a functional olfactory receptor, while in others, it remains non-functional due to gene disruption or mutation[2][5]. There are no approved drugs or clinical biomarkers associated with OR52Z1P, and it is **not considered a therapeutic target**. Its main relevance is in genetic studies of human olfaction, where pseudogenes like OR52Z1P help explain variability in smell perception between individuals. If an individual possesses the functional allele, the encoded protein would participate in odorant detection and initiate a G protein-mediated signaling cascade, yet no disease associations, pharmacological interventions, or therapeutic roles have been described for OR52Z1P specifically[2][3][5].

Other names
Olfactory receptor 52Z1POR52Z1POR52Z1Olfactory receptor 52Z1Odorant receptor HOR3'beta2Olfactory receptor, family 52, subfamily Z, member 1Olfactory receptor, family 52, subfamily Z, member 1 pseudogeneOlfactory receptor family 52 subfamily Z member 1 (Gene/Pseudogene)
02

Mechanism of action

None (pseudogene). If functional, would signal via G-protein-mediated cAMP cascade typical of olfactory GPCRs

03

Biological functions

None (for the pseudogene form; not transcribed or translated)Odorant recognition, signal transduction (if the allele is functional in certain individuals)
04

Disease associations

Other (no direct established role; possible variation in olfactory perception between individuals due to segregating pseudogene status)
05

Safety considerations

None documented; not a drug target
06

Interacting drugs

None documented (no known ligands, drugs, or approved molecules targeting this pseudogene; odorants are ligands for functional olfactory receptors in general)
07

Biomarkers

None known for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Olfactory receptor family 52 subfamily Z member 1 pseudogene (OR52Z1P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactory receptor family 52 subfamily Z member 1 pseudogene (OR52Z1P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call